[1] PORTAL-NÚÑEZ S, ESBRIT P, ALCARAZ MJ, et al. Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritis. Biochem Pharmacol. 2016;108:1-10.
[2] HUNTER DJ. Imaging insights on the epidemiology and pathophysiology of osteoarthritis. Rheum Dis Clin North Am. 2009;35(3):447-463.
[3] SHAMOON M, HOCHBERG MC. Treatment of osteoarthritis with acetaminophen: efficacy, safety, and comparison with nonsteroidal anti-inflammatory drugs. Curr Rheumatol Rep. 2000;2(6):454-458.
[4] Platas J, Guillén MI, Pérez Del Caz MD, et al. Paracrine effects of human adipose-derived mesenchymal stem cells in inflammatory stress-induced senescence features of osteoarthritic chondrocytes. Aging (Albany NY). 2016;8(8):1703-1717.
[5] KIM YG, CHOI J, KIM K. Mesenchymal Stem Cell-Derived Exosomes for Effective Cartilage Tissue Repair and Treatment of Osteoarthritis. Biotechnol J. 2020;15(12):e2000082.
[6] COSENZA S, TOUPET K, MAUMUS M, et al. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8(5):1399-1410.
[7] CASADO JG, BLÁZQUEZ R, VELA FJ, et al. Mesenchymal Stem Cell-Derived Exosomes: Immunomodulatory Evaluation in an Antigen-Induced Synovitis Porcine Model. Front Vet Sci. 2017;4:39.
[8] WU X, LI SH, LOU LM, et al. The effect of the microgravity rotating culture system on the chondrogenic differentiation of bone marrow mesenchymal stem cells. Mol Biotechnol. 2013;54(2):331-336.
[9] MURPHY C, WITHROW J, HUNTER M, et al. Emerging role of extracellular vesicles in musculoskeletal diseases. Mol Aspects Med. 2018;60:123-128.
[10] BURKE J, KOLHE R, HUNTER M, et al. Stem Cell-Derived Exosomes: A Potential Alternative Therapeutic Agent in Orthopaedics. Stem Cells Int. 2016;2016:5802529.
[11] HARRELL CR, JOVICIC N, DJONOV V, et al. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019;8(12):1605.
[12] VIZOSO FJ, EIRO N, COSTA L, et al. Mesenchymal Stem Cells in Homeostasis and Systemic Diseases: Hypothesis, Evidences, and Therapeutic Opportunities. Int J Mol Sci. 2019;20(15):3738.
[13] YAGHOUBI Y, MOVASSAGHPOUR A, ZAMANI M, et al. Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment. Life Sci. 2019;233:116733.
[14] LIU X, YANG Y, LI Y, et al. Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration. Nanoscale. 2017;9(13):4430-4438.
[15] MAO G, HU S, ZHANG Z, et al. Exosomal miR-95-5p regulates chondrogenesis and cartilage degradation via histone deacetylase 2/8. J Cell Mol Med. 2018;22(11):5354-5366.
[16] PATEL DB, SANTORO M, BORN LJ, et al. Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment. Biotechnol Adv. 2018;36(8):2051-2059.
[17] PRITZKER KP, GAY S, JIMENEZ SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006; 14(1):13-29.
[18] NAM Y, RIM YA, LEE J, et al. Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration. Stem Cells Int. 2018;2018:8490489.
[19] TOH WS, LAI RC, HUI JHP, et al. MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. Semin Cell Dev Biol. 2017;67:56-64.
[20] SUN L, XU R, SUN X, et al. Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell. Cytotherapy. 2016; 18(3):413-422.
[21] MIANEHSAZ E, MIRZAEI HR, MAHJOUBIN-TEHRAN M, et al. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res Ther. 2019;10(1):340.
[22] ZHANG R, MA J, HAN J, et al. Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis. Am J Transl Res. 2019;11(10): 6275-6289.
[23] TAO SC, YUAN T, ZHANG YL, et al. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017;7(1):180-195.
[24] WANG Y, YU D, LIU Z, et al. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res Ther. 2017; 8(1):189.
[25] ZHANG B, YIN Y, LAI RC, et al. Immunotherapeutic potential of extracellular vesicles. Front Immunol. 2014;5:518.
[26] ZHANG B, YIN Y, LAI RC, et al. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014;23(11):1233-1244.
[27] ZHANG S, CHUAH SJ, LAI RC, et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018;156:16-27.
[28] CHEN P, ZHENG L, WANG Y, et al. Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration. Theranostics. 2019;9(9):2439-2459.
[29] MAO G, ZHANG Z, HU S, et al. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A. Stem Cell Res Ther. 2018;9(1):247.
[30] WON LEE G, THANGAVELU M, JOUNG CHOI M, et al. Exosome mediated transfer of miRNA-140 promotes enhanced chondrogenic differentiation of bone marrow stem cells for enhanced cartilage repair and regeneration. J Cell Biochem. 2020;121(7):3642-3652.
[31] WU J, KUANG L, CHEN C, et al. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials. 2019;206:87-100.
[32] LIU Y, ZOU R, WANG Z, et al. Exosomal KLF3-AS1 from hMSCs promoted cartilage repair and chondrocyte proliferation in osteoarthritis. Biochem J. 2018;475(22):3629-3638.
[33] LIU Y, LIN L, ZOU R, et al. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis. Cell Cycle. 2018;17(21-22):2411-2422.
[34] YAN L, LIU G, WU X. Exosomes derived from umbilical cord mesenchymal stem cells in mechanical environment show improved osteochondral activity via upregulation of LncRNA H19. J Orthop Translat. 2020;26:111-120.
[35] YAN L, LIU G, WU X. The umbilical cord mesenchymal stem cell-derived exosomal lncRNA H19 improves osteochondral activity through miR-29b-3p/FoxO3 axis. Clin Transl Med. 2021;11(1):e255.
[36] HARASZTI RA, MILLER R, STOPPATO M, et al. Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity. Mol Ther. 2018;26(12):2838-2847.
|